Discovery Laboratories has announced that the FDA has approved the Afectair device for marketing in the US, and the company plans a launch later this year. The company describes Afectair as "a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support" and estimates that it could bring in … [Read more...] about Discovery Labs gets authorization for Afectair device in US
News
Mark Shepherd, Ben Cox join Team Consulting
Team Consulting has announced two new hires: Mark Shepherd, formerly Physical Properties Scientist in respiratory product development at GSK, and Human Factors and User Research Consultant Ben Cox. Shepherd, who has experience with dry powder and intranasal compounds, will be responsible for laboratory quality systems and procedures. “Having spent many years … [Read more...] about Mark Shepherd, Ben Cox join Team Consulting
Impax acquires rights to Zomig nasal spray
California-based Impax Pharmaceuticals has acquired exclusive US rights to several dosage forms of Zomig zolmitriptan, including the nasal spray formulation, from AstraZeneca. Zomig nasal spray is approved in the US for the treatment of migraine headaches. The agreement also gives Impax non-exclusive rights to develop and commercialize new zolmitriptan products. … [Read more...] about Impax acquires rights to Zomig nasal spray
Skye Pharma CEO Axel Mueller resigns
SkyePharma CEO Axel Mueller has resigned "to pursue other interests," according to the company, and will be replaced by current Chief Financial Officer Peter Grant. The company's announcement says that Grant, who has been CFO since 2006, "will retain responsibility for the Group's financial matters and will oversee the continuing activities to achieve Flutiform … [Read more...] about Skye Pharma CEO Axel Mueller resigns
Melbourn Scientific promotes Derek Solomon
Contract research organization Melbourn Scientific has announced the promotion of Derek Solomon to Operations Director, effective immediately. Solomon, who joined the company in 2005, previously held the title of Laboratory Manager and oversaw Melbourn's addition of formulation development and clinical manufacture to its services. Melbourn CEO Mark Hammond … [Read more...] about Melbourn Scientific promotes Derek Solomon
Valeant withdraws offer for ISTA
After having its first offer rejected by ISTA Pharmaceuticals, and after ISTA indicated that an increased offer was still insufficient, Valeant Pharmaceuticals has withdrawn its offer of $7.50 per share a day before its announced deadline of January 31, 2012. ISTA has several bepotastine nasal sprays in development for the treatment of allergic rhinitis. Valeant … [Read more...] about Valeant withdraws offer for ISTA
Company to launch THC e-cigarette in US
A company called Rapid Fire Marketing says that its subsidiary Medical Cannabis Management is launching a tetrahydrocannabinol (THC) e-cigarette in the US immediately and will follow with a second-generation device in 30-60 days. The device, called the CannaCig, is designed to deliver THC "in an oil form," according to the company, and will be sold through physicians … [Read more...] about Company to launch THC e-cigarette in US
Almirall and Galapagos partner to find new respiratory drug candidates
Spanish pharmaceutical company Almirall and Belgian biotech Galapagos have entered into a three-year agreement "aimed at delivering drug development candidates directed to a key respiratory target of interest to Almirall." According to the companies, the deal could be worth €7.5 million to Galapagos subsidiary BioFocus, which will be doing the research. Almirall's … [Read more...] about Almirall and Galapagos partner to find new respiratory drug candidates
Aptar opens new nasal/pulmonary device manufacturing facility in India
Aptar Pharma has opened a new manufacturing facility in Rabale, Navi Mumbai, India, where it will produce the DF30 metering valve for pressurized metered dose inhalers (MDIs) and spray pump assemblies for nasal spray delivery. The site was officially declared open on January 21, 2012 with a ceremony attended by the president of the Indian Pharmaceutical Association … [Read more...] about Aptar opens new nasal/pulmonary device manufacturing facility in India
Meda files patent infringement suit against Apotex, Perrigo
Meda Pharmaceuticals has filed a patent infringement suit against Apotex and Perrigo in US District Court in regard to their generic versions of its Astepro azelastine nasal spray for the treatment of rhinitis. The suit alleges infringement of a patent granted to Meda in December 2011 when the two companies submitted abbreviated new drug applications for generic … [Read more...] about Meda files patent infringement suit against Apotex, Perrigo